Wegovy pictures: the pen, the injection process, and what weight-loss results look like

What the Wegovy pen actually looks like, and why it matters if you're needle-wary

The Wegovy pen is a pre-filled, multi-dose auto-injector produced by Novo Nordisk. It is slim, roughly the size of a chunky marker pen, with a push-button mechanism and a small needle that extends and retracts automatically when you press it against the skin. Most people who are nervous about injections find the hidden-needle design considerably less intimidating than the conventional syringe images that tend to appear in search results.

Each pen contains four weekly doses, one per click. The dosing sequence starts at 0.25mg and steps up through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose, a titration schedule designed to let your body adjust and keep nausea manageable. A prescriber controls that schedule; the pen itself simply delivers what has been prescribed.

If you want to see the pen's physical design in detail, the most reliable images are on the manufacturer's own UK resources at wegovy.co.uk and in the patient information leaflet, which is indexed on the Electronic Medicines Compendium (eMC). Images elsewhere online may show older presentations, counterfeit pens, or the Ozempic pen, which is a different product entirely, licensed for type 2 diabetes, not weight loss. Our Wegovy overview page explains the distinction.

Injection site pictures, what correct technique looks like and what skin reactions can appear

A question our prescribers hear most weeks is whether a lump, redness or bruise at the injection site is normal. Usually, yes, mild local reactions are among the most common side effects listed by the NHS, and they typically settle within a few days, especially once injection technique is consistent.

Correct subcutaneous injection involves pinching a small fold of skin, inserting the needle at roughly a 90-degree angle (the auto-injector does this for you), and holding the pen in place for the count your leaflet specifies before withdrawing. Rotating between the abdomen, outer thigh and upper arm week by week prevents the skin thickening that repeated injections to the same spot can cause.

Occasionally, a more pronounced skin reaction develops: persistent redness, raised patches, or a rash that spreads beyond the injection site. If that happens, it is worth checking our page on Wegovy rash pictures, which covers what a normal local reaction looks like versus signs that warrant a call to your prescriber or pharmacist. For anything that spreads rapidly or is accompanied by swelling elsewhere, seek medical advice promptly rather than waiting for the next scheduled review.

Storage affects the pen's condition and, by extension, the medicine itself. Wegovy should be kept refrigerated at 2–8°C; exact room-temperature storage windows are set out in the patient information leaflet on the eMC, never rely on a forum or social media post for this detail.

Wegovy weight-loss pictures in context: what the trial results actually show

Wegovy weight-loss pictures circulate widely online, and the variation between them is striking, some show dramatic differences, others very little. That variation is real, not just cherry-picked. The STEP 1 trial, published in the New England Journal of Medicine, recorded an average body-weight reduction of around 15% over 68 weeks among participants taking semaglutide 2.4mg. Average is the operative word. Plenty of participants lost more; some lost considerably less; results depended on starting weight, adherence, dietary changes and other health factors.

Visual changes at 15% weight loss look different on different bodies. Someone starting at 120kg may lose around 18kg and see very obvious changes in face, waist and clothing. Someone starting at 85kg losing around 13kg may notice smaller but equally meaningful improvements in blood pressure, joint load and energy. Before-and-after images posted publicly tend to select for the most visually dramatic outcomes, which skews what feels "normal".

If you're using these pictures to decide whether Wegovy is worth exploring, a more useful frame is the clinical evidence and whether you'd meet the licensed eligibility criteria. Our semaglutide information page covers how the medicine works, including a closer look at the semaglutide structure that underpins its activity in the body, and our treatment overview sets out what a clinically supervised programme actually looks like. The right question isn't whether someone else's picture looks good, it's whether this treatment is appropriate for your health profile, which only a prescriber can assess.

What pictures can't tell you, and what to do next

There's one thing photographs of Wegovy results will never show: whether the treatment was clinically supervised, whether the supply chain was legitimate, or whether the person pictured maintained the lifestyle changes that the licence requires alongside the injection. Counterfeit pens are a documented problem in the UK; the MHRA has flagged large seizures of fake weight-loss pens sold through social media, some containing substances far removed from semaglutide, whose chemical structure makes accurate replication something only a licensed manufacturer can guarantee. A pen that looks right in a picture is no guarantee it is genuine.

Legitimate Wegovy in the UK comes through a licensed pharmacy, following a prescriber's assessment, and costs reflect that clinical infrastructure. If you want to understand what a private prescription route looks like, our guide on where to buy Wegovy in the UK explains how to verify any online pharmacy on the GPhC register and what red flags to watch for.

Pictures are a reasonable starting point for curiosity. They are not a substitute for a clinical conversation. If Wegovy looks like something worth exploring, the next step is a free consultation where a GPhC-registered prescriber reviews your health information personally. Speak to our prescribers at our weight-loss treatments page to get started.